Changes in illicit drug use and markets with the COVID-19 pandemic and associated restrictions: findings from the Ecstasy and Related Drugs Reporting System, 2016-20.
Big events
COVID-19
MDMA
drug markets
harms
illicit drug
pandemic
Journal
Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
revised:
02
02
2021
received:
16
11
2020
accepted:
09
06
2021
pubmed:
24
6
2021
medline:
15
12
2021
entrez:
23
6
2021
Statut:
ppublish
Résumé
To describe (i) self-reported changes in drug use and (ii) trends in price, perceived availability, and perceived purity of illicit drugs, among people who regularly use ecstasy/ 3,4-methylenedioxymethamphetamine (MDMA) and other illicit stimulants in Australia following COVID-19 and associated restrictions. Annual interviews with cross-sectional sentinel samples conducted face-to-face in 2016-19 and via video conferencing or telephone in 2020. Data were collected via an interviewer-administered structured questionnaire. Australian capital cities. Australians aged 16 years or older who used ecstasy/MDMA and other illicit stimulants on a monthly or more frequent basis and resided in a capital city, recruited via social media and word-of-mouth (n ~ 800 each year). Key outcome measures were self-reported illicit drug market indicators (price, purity and availability) and, in 2020 only, perceived change in drug use (including alcohol and tobacco) since March 2020 and reasons for this change. For most drugs, participants reported either no change or a reduction in their use since COVID-19 restrictions were introduced. Ecstasy/MDMA was the drug most frequently cited as reduced in use (n = 552, 70% of those reporting recent use), mainly due to reduced opportunities for socialization. While market indicators were largely stable across most drugs, the odds of perceiving MDMA capsules as 'high' in purity decreased compared with 2016-19 [adjusted odds ratio (aOR) = 0.72, 95% confidence interval (CI) = 0.53-0.99], as did perceiving them as 'easy' to obtain (aOR = 0.42, CI = 0.26-0.67). The odds of perceiving cocaine and methamphetamine crystal as 'easy' to obtain also decreased (aOR = 0.67, CI = 0.46-0.96 and aOR = 0.12, CI = 0.04-0.41, respectively). After COVID-19-related restrictions were introduced in Australia, use of ecstasy/MDMA, related stimulants and other licit and illicit drugs mainly appeared to remain stable or decrease, primarily due to impediments to socialization.
Identifiants
pubmed: 34159666
doi: 10.1111/add.15620
pmc: PMC8441814
mid: NIHMS1716539
doi:
Substances chimiques
Illicit Drugs
0
N-Methyl-3,4-methylenedioxyamphetamine
KE1SEN21RM
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
182-194Subventions
Organisme : Australian Government Department of Health
Organisme : National Institute of Health (NIH) grants National Institute on Drug Abuse (NIDA)
ID : R01DA1104470
Organisme : NHMRC Investigator Fellowship
ID : 1174630
Organisme : NHMRC Senior Principal Research Fellowship
ID : 1135991
Organisme : The National Drug Research Institute at Curtin University
Organisme : NIDA NIH HHS
ID : R01 DA044170
Pays : United States
Informations de copyright
© 2021 Society for the Study of Addiction.
Références
Addiction. 2015 Jan;110(1):120-8
pubmed: 25220170
Drug Test Anal. 2014 Jul-Aug;6(7-8):840-5
pubmed: 24574080
Drug Alcohol Depend. 1998 Aug 1;51(3):253-63; discussion 267-8
pubmed: 9787998
Drug Alcohol Rev. 2020 May;39(4):297-300
pubmed: 32445265
Lancet. 2019 Nov 2;394(10209):1668-1684
pubmed: 31668410
Addiction. 2005 Jul;100(7):908-20
pubmed: 15954999
BMC Res Notes. 2018 Jun 4;11(1):349
pubmed: 29866161
Subst Use Misuse. 2021;56(2):238-244
pubmed: 33317365
IEEE Trans Vis Comput Graph. 2014 Dec;20(12):1983-92
pubmed: 26356912
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1049-1057
pubmed: 32790653
Curr Opin Psychiatry. 2020 Jul;33(4):319-325
pubmed: 32250985
Int J Environ Res Public Health. 2016 Jan 13;13(1):
pubmed: 26771628
Drug Alcohol Depend. 2020 Nov 1;216:108260
pubmed: 32890975
JAMA Psychiatry. 2021 Apr 1;78(4):372-379
pubmed: 33533876
Drug Alcohol Depend. 2007 Sep;90 Suppl 1:S61-8
pubmed: 16971056
Addiction. 2022 Jan;117(1):182-194
pubmed: 34159666
Subst Use Misuse. 2015;50(7):885-90
pubmed: 25723311